期刊文献+

307例女性乳腺髓样癌报告 被引量:6

Mortality Analysis of 307 Cases with Modullary Breast Carcinoma
下载PDF
导出
摘要 本文总结了307例经治的中国女性乳腺髓样癌。根据Ridolfi等制定的诊断标准(cancer,1977,40:1365~1386),分为92例(29.9%)典型髓样癌和215例(70.0%)非典型髓样癌。结果表明92例典型髓样癌和215例非典型髓样癌的10年生存率分别为84.8%(78/92)和73.0%(157/215)。腋窝淋巴结的转移情况被认为是影响预后的重要因素,在腋窝淋巴结无转移组56例典型髓样癌和114例非典型髓样癌的10年生存率分别为92.9%(52/56)和86.0%(98/114),而在腋窝淋巴结有转移时分别为72.2%(26/36)和49.5%(50/101)。乳腺髓样癌具有良好的组织学特征和预后效果,特别是腋窝淋巴结阴性的典型髓样癌的预后效果最佳。 307 female patients with medullary carinoma of breast are analysed retrospectively. According to the criteria of Ridolfi et al 92 patients(29.9%)suffered from typical medullary carcinoma and 215 patients(70.0%)from atypical one.All patients underwent radical mastectomy with chemotherapy or radical mastectomy with chemotherapy and irradiation.The results showed that 10 years surival rate was 84.8% and 73.0% in patients with typical medullary carcinoma(78/92 cases)and patients with atypical medullary carcinoma respectively(157/215 cases).The microscopical auxillary lymph nodes status were considered to be the most important prognostic factor.In the group without mestastases(PNO)52 patients survived 10yesrs in 56 cases(92.9%)with typical carcinoma and 98 patients in 114 caces with atypical carcinoma(86.6%).However,in metastases positive(PN+)group they were 72.2%(26/36 cases)and 49.6%(50/101cases)only.Medullary carcinoma of the berast had a favorable histological characteristics and prognostic results.Especially,the prognosis of typical medullary carcinoma for PNO patients was much better than the atypical medullary carcinoma.
作者 顾林 马淑资
机构地区 天津市肿瘤医院
出处 《中国中西医结合外科杂志》 CAS 1997年第3期164-167,共4页 Chinese Journal of Surgery of Integrated Traditional and Western Medicine
关键词 乳腺髓样癌 乳腺癌 根治术 放射疗法 药物疗法 typical medullary carcinoma,atyical medullary carcinoma,radical mastectomy,irradiation,chemotherapy,prognosis.
  • 相关文献

同被引文献40

  • 1邹天宁,汤学良,张勇,陈文林.乳腺髓样癌61例临床分析[J].云南医药,2005,26(2):104-105. 被引量:5
  • 2张晓明,范嫏娣.乳腺典型髓样癌与不典型髓样癌临床病理分析[J].临床与实验病理学杂志,2005,21(4):438-441. 被引量:10
  • 3李晓曦,王深明,赖远辉,李松奇.乳腺髓样癌的治疗[J].中华外科杂志,2005,43(23):1516-1518. 被引量:4
  • 4王德延.乳腺癌组织学类型与预后的研究[J].肿瘤临床,1985,12:135-135.
  • 5Perkins GH,Green MC,Middleton LP,et al.Medullary breast carcinoma:outcomes and prognosis with the utilization of chemotherapy.J Clin Oncol,2004,22:671.
  • 6Adler DD,Carson PL,Rubin JM,et al.Doppler ultrasound color flow imaging in the study of breast cancer:preliminary findings.Ultrasound Med Biol,1990,16(6):553-559.
  • 7Chao TC,Lo YF,Chen SC,et al.Color Doppler ultrasound in benign and malignant breast tumors.Breast Cancer Res Treat,1999,57(2):193-199.
  • 8Yoshji H,Gomez DE,Shibuya M,et al.Experession of vascular endothelial growth factor,its receptors,and other angiogenic factors in human breast cancer.Cancer Res,1996,56(9):2013-2016.
  • 9Sehgal CM,Argen PH,Rowling SE,et al.Quantitative vascularity of breast masses by Doppler imaging:regional variations and diagnostic implications.J Ultrasound Med,2000,19:427-440.
  • 10MATKOVIC B,JURETIC A,SEPAROVIC V,et al.Immunohistochemical analysis of ER,PR,HER-2,CK 5/6,p63 and EGFR antigen expression in medullary breast cancer[J].Tumori,2008,94(6):838-844.

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部